Convergence Investment Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,012
Closed -$245K 246
2021
Q3
$245K Buy
+1,012
New +$255K 0.13% 167
2018
Q2
Sell
-23,562
Closed -$3.27M 631
2018
Q1
$3.27M Buy
+23,562
New +$3.46M 0.43% 92

Other funds holding LH

Convergence Investment Partners's LH Position: Q4 2021 in Review

Convergence Investment Partners sold out of Labcorp (LH) in Q4 2021, closing a stake of 1,012 shares — an estimated $245K sold.

Convergence Investment Partners first reported a position in LH in Q1 2018 and held it in 2 quarters. The position peaked at $3.27M in Q1 2018. 1,061 funds tracked by Wall St. Rank hold LH as of Q4 2021.

  • Convergence Investment Partners reported no remaining Labcorp position as of Q4 2021 after selling out during the quarter.
  • Convergence Investment Partners sold 1,012 Labcorp shares in Q4 2021, an estimated $245K.
  • Convergence Investment Partners first reported a position in Labcorp in Q1 2018 and held it in 2 quarters.
  • Convergence Investment Partners's Labcorp position peaked at $3.27M in Q1 2018.
  • 1,061 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.

Based on Convergence Investment Partners's 13F filing for Q4 2021, filed 25 Jan 2022.